We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$527B
AUM Growth
-$50.5B
Cap. Flow
-$9.14B
Cap. Flow %
-1.73%
Top 10 Hldgs %
31.73%
Holding
16,069
New
1,671
Increased
6,327
Reduced
6,228
Closed
1,709

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.44B
2
QQQ icon
Invesco QQQ Trust
QQQ
+$1.15B
3
GEHC icon
GE HealthCare
GEHC
+$552M
4
DHR icon
Danaher
DHR
+$447M
5
MSTR icon
Strategy Inc
MSTR
+$416M

Sector Composition

Rank Sector Weight
1 Healthcare 3.24%
2 Technology 2.87%
3 Financials 2.43%
4 Consumer Discretionary 2.22%
5 Industrials 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORMP icon
14301
Oramed Pharmaceuticals
ORMP
$186M
$71 ﹤0.01%
33
-72,456
-100% -$167K
PEGA icon
14302
Pegasystems
PEGA
$5.31B
$70 ﹤0.01%
2
-422,166
-100% -$18.7M
EVTL icon
14303
CALL
Vertical Aerospace
EVTL
$106M
$67 ﹤0.01%
+20
New +$112
FRSX
14304
PUT
Foresight Autonomous Holdings
FRSX
$3.87M
$65 ﹤0.01%
+5
New +$103
CTMX icon
14305
CytomX Therapeutics
CTMX
$732M
$64 ﹤0.01%
100
-322,211
-100% -$250K
INCY icon
14306
Incyte
INCY
$24.4B
$61 ﹤0.01%
1
-229,868
-100% -$16M
TLPH icon
14307
PUT
Talphera
TLPH
$63.8M
$50 ﹤0.01%
+100
New +$61
LVLU icon
14308
PUT
Lulu's Fashion Lounge
LVLU
$46.6M
$40 ﹤0.01%
+7
New +$79
EQ icon
14309
PUT
Equillium
EQ
$149M
$39 ﹤0.01%
+100
New +$75
MCRB icon
14310
Seres Therapeutics
MCRB
$45.6M
$34 ﹤0.01%
2
OVID icon
14311
PUT
Ovid Therapeutics
OVID
$528M
$31 ﹤0.01%
100
-100
-50% -$61
ACHC icon
14312
Acadia Healthcare
ACHC
$2.87B
$30 ﹤0.01%
1
-1,900,267
-100% -$72.4M
IPG
14313
DELISTED
Interpublic Group of Companies
IPG
$27 ﹤0.01%
1
-618,248
-100% -$17M
HTOO icon
14314
PUT
Fusion Fuel Green
HTOO
$16.8M
$26 ﹤0.01%
3
-431
-99% -$6.52K
PACB icon
14315
Pacific Biosciences
PACB
$357M
$26 ﹤0.01%
22
-360,959
-100% -$554K
PRLD icon
14316
Prelude Therapeutics
PRLD
$443M
$26 ﹤0.01%
34
-10,263
-100% -$9.57K
KG
14317
Kestrel Group
KG
$61.7M
$13 ﹤0.01%
1
-6,175
-100% -$116K
LVO icon
14318
LiveOne
LVO
$57.2M
$8 ﹤0.01%
+1
New +$10
WW
14319
DELISTED
WW International
WW
$4 ﹤0.01%
7
-170,604
-100% -$148K
AAXJ icon
14320
CALL
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
-100
Closed -$7.22K
AAXJ icon
14321
PUT
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.84B
-4,500
Closed -$325K
ABEQ icon
14322
Absolute Select Value ETF
ABEQ
$145M
-12,996
Closed -$409K
ABEV icon
14323
Ambev
ABEV
$43.2B
-2,053,900
Closed -$4.11M
ABOS icon
14324
Acumen Pharmaceuticals
ABOS
$193M
-9,597
Closed -$13.7K
ABR icon
14325
Arbor Realty Trust
ABR
$950M
-231,363
Closed -$2.99M

Similar funds

Ken Griffin's Q1 2025 Portfolio in Review

As of Q1 2025, Ken Griffin held 16,069 positions worth $527B, down 8.7% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Ken Griffin's Q1 2025 filing shows 1,671 new, 6,327 increased, 6,228 reduced and 1,709 closed positions. Its largest new stake was CMS Energy: 1,417,315 shares worth $106M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $989M.

By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 3.1% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q1 2025 buy was CMS Energy: 1,417,315 shares worth $106M.
  • Ken Griffin added most to Charles Schwab in Q1 2025, an estimated $1.44B increase.
  • Ken Griffin's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $989M.
  • Ken Griffin fully exited Walmart Inc in Q1 2025, selling an estimated $462M.
  • Ken Griffin's ten largest holdings make up 32% of its $527B portfolio in Q1 2025.
  • Ken Griffin opened 1,671 new positions and closed 1,709 in Q1 2025.
  • Ken Griffin's portfolio value fell 8.7% quarter-over-quarter to $527B.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.